ILMN
Illumina Inc
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
at illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. these studies will help make the realization of personalized medicine possible. with such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. as a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. illumina’s innovative, array-based solutions for dna, rna, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
Market Cap: 21.5 Billion
Primary Exchange: NASDAQ
Website: https://www.illumina.com
Shares Outstanding: 159 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 1.226460716710565
Sector: Manufacturing
Industry: Analytical Laboratory Instrument Manufacturing
Ethical Flags
Longest drawdown: 810 trading days
From: 2021-08-16 To: 2024-03-07
Lowest Point:
Illumina, Inc. (ILMN) CEO Francis deSouza Presents at Goldman Sachs Global Healthcare Conference (Transcript)
via: SeekingAlpha at 2019-06-12 14:09:06:000
Illumina, Inc. (ILMN) Goldman Sachs Global Healthcare Conference June 12, 2019, 03:00 PM ET Company Participants Francis deSouza - CEO Conference Call Participants Patrick Donnelly - Goldman Sachs Presentation Patrick Donnelly I think we can look to get started. Thank… read more...
Illumina, Inc. (ILMN) CEO Francis deSouza Presents at Goldman Sachs Global Healthcare Conference (Transcript)
via: SeekingAlpha at 2019-06-12 14:09:06:000
Illumina, Inc. (ILMN) Goldman Sachs Global Healthcare Conference June 12, 2019, 03:00 PM ET Company Participants Francis deSouza - CEO Conference Call Participants Patrick Donnelly - Goldman Sachs Presentation Patrick Donnelly I think we can look to get started. Thank… read more...
Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q1 2019 Update
via: SeekingAlpha at 2019-06-12 01:06:09:000
This article is part of a series that provides an ongoing analysis of the changes made to Ole Andreas Halvorsens 13F stock portfolio on a quarterly basis. It is based on Viking Globals regulatory 13F Form filed on 05/15/2019. Please visit our Tracking Ole Andreas Halvorsen… read more...
Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q1 2019 Update
via: SeekingAlpha at 2019-06-12 01:06:09:000
This article is part of a series that provides an ongoing analysis of the changes made to Ole Andreas Halvorsens 13F stock portfolio on a quarterly basis. It is based on Viking Globals regulatory 13F Form filed on 05/15/2019. Please visit our Tracking Ole Andreas Halvorsen… read more...
Merger Arbitrage Analysis And Spread Performance - June 9, 2019
via: SeekingAlpha at 2019-06-10 08:09:58:000
This article explains the reasons behind the movement in a selection of the largest U.S. cash merger arbitrage spreads from the past week as calculated by Merger Arbitrage Limited . We analyze the attractiveness and profitability of each spread going forward and indicate the trading position … read more...
Merger Arbitrage Analysis And Spread Performance - June 9, 2019
via: SeekingAlpha at 2019-06-10 08:09:58:000
This article explains the reasons behind the movement in a selection of the largest U.S. cash merger arbitrage spreads from the past week as calculated by Merger Arbitrage Limited . We analyze the attractiveness and profitability of each spread going forward and indicate the trading position … read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|